體外診斷包裝市場機會、成長動力、產業趨勢分析與 2025 - 2034 年預測

2024 年全球體外診斷包裝市場估值達 86 億美元，預計 2025 年至 2034 年期間複合年成長率為 5.1%。主要促進因素之一是新興市場對在地化製造和包裝解決方案的需求不斷增加。這些地區的醫療保健基礎設施正在快速發展，導致診斷測試數量增加，迫切需要確保這些測試完整性的包裝解決方案。因此，越來越多的公司開始專注於包裝創新，以滿足這些發展中市場的特定需求。個人化醫療、即時診斷檢測的趨勢以及已開發地區人口老化日益加劇，進一步推動了對高品質 IVD 包裝的需求。人們更加重視診斷測試的安全性和精確度，這進一步推動了這種成長。

就產品類型而言，市場分為管、瓶和小瓶、培養皿、封蓋和其他包裝解決方案。其中，到 2034 年，瓶子和小瓶部分預計將產生 40 億美元的收入。它們的多功能性使其具有廣泛的應用範圍，從儲存血液和尿液樣本到包裝分子和生化試劑。這種廣泛的適用性使得瓶子和小瓶子在 IVD 行業中繼續成為不可或缺的一部分。

IVD包裝市場也看到來自各種終端使用者的需求，包括醫院、實驗室、學術機構等。其中，學術機構部分預計成長最快，2025 年至 2034 年期間的複合年成長率為 7%。學術機構在推動醫學研究方面發揮關鍵作用，包括開發新的診斷測試、試劑和技術。隨著研究活動的擴大，對維持生物樣本和試劑的完整性和穩定性的專門包裝解決方案的需求也日益成長。研發投資的激增和研究驅動計畫的擴展只會增加對學術目的的先進封裝解決方案的需求。

在北美，IVD包裝市場佔有相當大的佔有率，到2024年將占到整個市場的35%。隨著人口老化加劇，對個人化醫療和即時診斷檢測等先進診斷解決方案的需求不斷成長，並繼續推動市場擴張。隨著醫療保健提供者和機構努力尋求更有效、更有效率的診斷解決方案，北美對高品質、專業化 IVD 包裝的需求仍然是該地區市場成長的關鍵因素。

目錄

第 1 章：方法論與範圍

• 市場範圍和定義
• 基礎估算與計算
• 預測計算
• 資料來源
  • 基本的
  • 次要
    • 付費來源
    • 公共資源

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
  • 影響價值鏈的因素
  • 利潤率分析
  • 中斷
  • 未來展望
  • 製造商
  • 經銷商
• 重要新聞及舉措
• 監管格局
• 衝擊力
  • 成長動力
    • 診斷測試解決方案的需求不斷成長
    • IVD 包裝技術的進步
    • 新興市場的醫療保健擴張
    • 對本地製造和包裝的需求
    • 更重視永續包裝解決方案
  • 產業陷阱與挑戰
    • 專業包裝解決方案成本高
    • 滿足複雜的監管要求
• 成長潛力分析
• 波特的分析
• PESTEL 分析

第4章：競爭格局

• 介紹
• 公司市佔率分析
• 競爭定位矩陣
• 戰略展望矩陣

第 5 章：市場估計與預測：按產品，2021-2034 年

• 主要趨勢
• 瓶子和小瓶
• 管
• 培養皿
• 閉包
• 其他

第 6 章：市場估計與預測：按應用，2021 年至 2034 年

• 主要趨勢
• 糖尿病
• 傳染病
• 心臟病學
• 自體免疫疾病
• 腫瘤學
• 藥物檢測
• 其他

第 7 章：市場估計與預測：依最終用途，2021 年至 2034 年

• 主要趨勢
• 醫院
• 實驗室
• 學術機構
• 其他

第 8 章：市場估計與預測：按地區，2021 年至 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 法國
  • 義大利
  • 西班牙
  • 俄羅斯
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲
• 拉丁美洲
  • 巴西
  • 墨西哥
• 中東及非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第9章：公司簡介

• Abdos Labtech
• Academy Medical Instruments
• AdvaCare Pharma
• Amcor
• Amrit Scientific
• Ajosha Bio Teknik
• Aptargroup
• Corning
• Focus Technology
• Fusion Biotech
• Globe Scientific
• Greiner Holding
• Kindly Group
• Labtech Disposables
• Narang Medical
• Oliver
• Peacock Industries
• VWR International
• Yuhuan Kangjia
• Zhuhai Ideal Biotech

The Global In-Vitro Diagnostics Packaging Market reached a valuation of USD 8.6 billion in 2024 and is estimated to grow at a CAGR of 5.1% from 2025 to 2034. The market's upward trajectory is driven by several factors. One of the primary drivers is the increasing demand for localized manufacturing and packaging solutions in emerging markets. These regions are seeing rapid advancements in healthcare infrastructure, resulting in an uptick in diagnostic tests and an urgent need for packaging solutions that ensure the integrity of these tests. As a result, more companies are focusing on packaging innovations that cater to the specific needs of these developing markets. The trend toward personalized medicine, point-of-care testing, and the growing aging population in developed regions further contribute to the demand for high-quality IVD packaging. This growth is further fueled by a greater focus on safety and precision in diagnostic testing.

In terms of product types, the market is segmented into tubes, bottles and vials, petri dishes, closures, and other packaging solutions. Of these, the bottles and vials segment is expected to generate USD 4 billion through 2034. These packaging solutions are essential in the IVD sector, providing crucial protection against contamination, moisture, and light, which helps preserve the stability and accuracy of diagnostic reagents and samples. Their versatility allows for a wide array of applications, from the storage of blood and urine samples to packaging molecular and biochemical reagents. This broad applicability continues to make bottles and vials indispensable in the IVD industry.

The IVD packaging market also sees demand from various end users, including hospitals, laboratories, academic institutions, and others. Among these, the academic institutions segment is projected to grow the fastest, with a CAGR of 7% between 2025 and 2034. This growth can be attributed to the increasing investments in research and development in diagnostic technologies. Academic institutions play a pivotal role in advancing medical research, including the development of new diagnostic tests, reagents, and techniques. As research activities expand, the need for specialized packaging solutions that maintain the integrity and stability of biological samples and reagents grows. The surge in R&D investments and the expansion of research-driven initiatives will only intensify the demand for advanced packaging solutions tailored for academic purposes.

In North America, the IVD packaging market holds a significant share, accounting for 35% of the total market in 2024. This dominance is largely driven by the region's leadership in medical technology innovation, with considerable investments in research and development, especially in diagnostic technologies. The rising demand for advanced diagnostic solutions, such as personalized medicine and point-of-care testing, coupled with the aging population, continues to fuel market expansion. As healthcare providers and institutions strive for more effective and efficient diagnostic solutions, the need for high-quality, specialized IVD packaging in North America remains a key factor in the region's market growth.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Base estimates & calculations
• 1.3 Forecast calculations
• 1.4 Data sources
  • 1.4.1 Primary
  • 1.4.2 Secondary
    • 1.4.2.1 Paid sources
    • 1.4.2.2 Public sources

Chapter 2 Executive Summary

• 2.1 Industry synopsis, 2022-2034

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
  • 3.1.1 Factor affecting the value chain
  • 3.1.2 Profit margin analysis
  • 3.1.3 Disruptions
  • 3.1.4 Future outlook
  • 3.1.5 Manufacturers
  • 3.1.6 Distributors
• 3.2 Key news & initiatives
• 3.3 Regulatory landscape
• 3.4 Impact forces
  • 3.4.1 Growth drivers
    • 3.4.1.1 Rising demand for diagnostic test solutions
    • 3.4.1.2 Advancements in IVD packaging technologies
    • 3.4.1.3 Expansion of healthcare in emerging markets
    • 3.4.1.4 Demand for local manufacturing and packaging
    • 3.4.1.5 Increasing focus on sustainable packaging solutions
  • 3.4.2 Industry pitfalls & challenges
    • 3.4.2.1 High costs of specialized packaging solutions
    • 3.4.2.2 Navigating complex regulatory requirements
• 3.5 Growth potential analysis
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategic outlook matrix

Chapter 5 Market Estimates & Forecast, By Product, 2021-2034 (USD Million & Kilo Tons)

• 5.1 Key trends
• 5.2 Bottles and vials
• 5.3 Tubes
• 5.4 Petri dishes
• 5.5 Closures
• 5.6 Others

Chapter 6 Market Estimates & Forecast, By Application, 2021-2034 (USD Million & Kilo Tons)

• 6.1 Key trends
• 6.2 Diabetes
• 6.3 Infectious diseases
• 6.4 Cardiology
• 6.5 Autoimmune diseases
• 6.6 Oncology
• 6.7 Drug testing
• 6.8 Others

Chapter 7 Market Estimates & Forecast, By End Use, 2021-2034 (USD Million & Kilo Tons)

• 7.1 Key trends
• 7.2 Hospitals
• 7.3 Laboratories
• 7.4 Academic institutes
• 7.5 Others

Chapter 8 Market Estimates & Forecast, By Region, 2021-2034 (USD Million & Kilo Tons)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 UK
  • 8.3.2 Germany
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Russia
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 India
  • 8.4.3 Japan
  • 8.4.4 South Korea
  • 8.4.5 Australia
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
• 8.6 MEA
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 UAE

Chapter 9 Company Profiles

• 9.1 Abdos Labtech
• 9.2 Academy Medical Instruments
• 9.3 AdvaCare Pharma
• 9.4 Amcor
• 9.5 Amrit Scientific
• 9.6 Ajosha Bio Teknik
• 9.7 Aptargroup
• 9.8 Corning
• 9.9 Focus Technology
• 9.10 Fusion Biotech
• 9.11 Globe Scientific
• 9.12 Greiner Holding
• 9.13 Kindly Group
• 9.14 Labtech Disposables
• 9.15 Narang Medical
• 9.16 Oliver
• 9.17 Peacock Industries
• 9.18 VWR International
• 9.19 Yuhuan Kangjia
• 9.20 Zhuhai Ideal Biotech